Literature DB >> 23286757

Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

Walter G Bradley1, Amy R Borenstein, Lorene M Nelson, Geoffrey A Codd, Barry H Rosen, Elijah W Stommel, Paul Alan Cox.   

Abstract

There is a broad scientific consensus that amyotrophic lateral sclerosis (ALS) is caused by gene-environment interactions. Mutations in genes underlying familial ALS (fALS) have been discovered in only 5-10% of the total population of ALS patients. Relatively little attention has been paid to environmental and lifestyle factors that may trigger the cascade of motor neuron death leading to the syndrome of ALS, although exposure to chemicals including lead and pesticides, and to agricultural environments, smoking, certain sports, and trauma have all been identified with an increased risk of ALS. There is a need for research to quantify the relative roles of each of the identified risk factors for ALS. Recent evidence has strengthened the theory that chronic environmental exposure to the neurotoxic amino acid β-N-methylamino-L-alanine (BMAA) produced by cyanobacteria may be an environmental risk factor for ALS. Here we describe methods that may be used to assess exposure to cyanobacteria, and hence potentially to BMAA, namely an epidemiologic questionnaire and direct and indirect methods for estimating the cyanobacterial load in ecosystems. Rigorous epidemiologic studies could determine the risks associated with exposure to cyanobacteria, and if combined with genetic analysis of ALS cases and controls could reveal etiologically important gene-environment interactions in genetically vulnerable individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23286757     DOI: 10.3109/21678421.2012.750364

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  30 in total

1.  Assessing the Combined Toxicity of BMAA and Its Isomers 2,4-DAB and AEG In Vitro Using Human Neuroblastoma Cells.

Authors:  Brendan J Main; Kenneth J Rodgers
Journal:  Neurotox Res       Date:  2017-06-20       Impact factor: 3.911

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

3.  Use of three monitoring approaches to manage a major Chrysosporum ovalisporum bloom in the Murray River, Australia, 2016.

Authors:  Adam Crawford; Jon Holliday; Chester Merrick; John Brayan; Mark van Asten; Lee Bowling
Journal:  Environ Monit Assess       Date:  2017-03-31       Impact factor: 2.513

4.  Perinatal Exposure to the Cyanotoxin β-N-Méthylamino-L-Alanine (BMAA) Results in Long-Lasting Behavioral Changes in Offspring-Potential Involvement of DNA Damage and Oxidative Stress.

Authors:  Anthony Laugeray; Asma Oummadi; Clément Jourdain; Justyne Feat; Géraldine Meyer-Dilhet; Arnaud Menuet; Karen Plé; Marion Gay; Sylvain Routier; Stéphane Mortaud; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

5.  Marine harmful algal blooms, human health and wellbeing: challenges and opportunities in the 21st century.

Authors:  Elisa Berdalet; Lora E Fleming; Richard Gowen; Keith Davidson; Philipp Hess; Lorraine C Backer; Stephanie K Moore; Porter Hoagland; Henrik Enevoldsen
Journal:  J Mar Biol Assoc U K       Date:  2015-11-20       Impact factor: 1.394

Review 6.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

7.  Mechanisms of L-Serine Neuroprotection in vitro Include ER Proteostasis Regulation.

Authors:  R A Dunlop; J Powell; G J Guillemin; P A Cox
Journal:  Neurotox Res       Date:  2017-11-02       Impact factor: 3.911

Review 8.  BMAA and Neurodegenerative Illness.

Authors:  Paul Alan Cox; Richard M Kostrzewa; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-05-24       Impact factor: 3.911

9.  An evaluation of a handheld spectroradiometer for the near real-time measurement of cyanobacteria for bloom management purposes.

Authors:  Lee C Bowling; Mustak Shaikh; John Brayan; Tim Malthus
Journal:  Environ Monit Assess       Date:  2017-09-09       Impact factor: 2.513

10.  Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.

Authors:  Hong Z Yin; Stephen Yu; Cheng-I Hsu; Joe Liu; Allan Acab; Richard Wu; Anna Tao; Benjamin J Chiang; John H Weiss
Journal:  Exp Neurol       Date:  2014-06-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.